TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

PGI may start in-house testing of medicines

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement
Advertisement

Chandigarh, October 31

Advertisement

The PGI is considering starting testing of medicines to avert any adverse reaction to patients. The move comes after five such cases relating to Propofol, an anaesthetic drug, surfaced at the institute.

Central Drug Testing Laboratory is one of the seven national laboratories in India engaged in the research and analysis of drug and cosmetics as per the Drug and Cosmetics Act, 1940. “unexplained” hypotension (sudden drop in blood pressure) in intraoperative (occurring or performed during the course of a surgical operation) period with anuria (failure of the kidneys to produce urine) and/or jaundice in post-operative period were found in a few patients over the past few days. The matter was highlighted on September 1.

Advertisement
Advertisement
Show comments
Advertisement